BioSpace News Archive

Business

Cyclica launches Perturba Therapeutics, a spin out from the University of Toronto, creating the next-generation oncology biotech

Cyclica Inc. (“Cyclica”), a neo-biotech with the vision to advance the most robust and sustainable drug discovery pipeline, today launches Perturba Therapeutics Inc. (“Perturba”), a spin out from the Stagljar Lab at the University of Toronto, Donnelly Centre for Cellular and Biomolecular Research.

February 9, 2022

·

5 min read

Genetown

CRISPR Therapeutics to Participate in the 11th Annual SVB Leerink Global Healthcare Conference

CRISPR Therapeutics announced that members of its senior management team are scheduled to participate in the 11th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 16, 2022, at 1:40 p.m. ET.

February 9, 2022

·

1 min read

BioCapital

NeoImmuneTech to Present at Upcoming Business Conferences

NeoImmuneTech, Inc., a clinical-stage T cell-focused biopharmaceutical company, announced that its Chief Business Officer, Sam Zhang, Ph.D., MBA, will present at the upcoming BIO CEO and Investor Conference, to be held February 14-17 in New York, NY.

February 9, 2022

·

3 min read

Business

Ligand to Report Fourth Quarter Financial Results on February 17

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) will report fourth quarter 2021 financial results after the close of the U.S. financial markets on Thursday, February 17, 2022 and will hold a conference call that same day beginning at 4:30 p.m. Eastern time.

February 9, 2022

·

2 min read

Össur Launches New POWER KNEE - World’s First Actively Powered Lower Limb Bionic Prosthesis for Amputees

Össur today launched its new POWER KNEE, the world’s first actively powered microprocessor prosthetic knee for people with above-knee amputation or limb difference.

February 9, 2022

·

2 min read

Business

BIONIK Laboratories Reports Third Quarter Fiscal Year 2022 Financial Results

BIONIK Laboratories Corp. today reported financial results for the third quarter and first nine months of fiscal year 2022, ended December 31, 2021.

February 9, 2022

·

13 min read

Genetown

Selecta Biosciences to Participate at the SVB Leerink 11th Annual Global Healthcare Conference

Selecta Biosciences, Inc. announced that Company’s Management will provide a corporate update and participate in one-on-one investor meetings at the SVB Leerink 11th Annual Global Healthcare Conference, to be held virtually February 14-18, 2022.

February 9, 2022

·

1 min read

Business

Checkmate Pharmaceuticals Appoints Alan Bash as President and CEO

Checkmate Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on developing its proprietary technology to harness the power of the immune system to combat cancer, announced the appointment of Alan Bash as President and Chief Executive Officer, effective March 1, 2022.

February 9, 2022

·

6 min read

Deals

Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fusion Pharmaceuticals Inc. today announced that the compensation committee of the Company’s Board of Directors granted stock option awards to purchase an aggregate of 12,600 shares.

February 9, 2022

·

2 min read

FDA

FDA Awards QIDP Designation for Prevention of Chlamydia to Evofem Biosciences

Evofem Biosciences, Inc., announced today that the U.S. Food and Drug Administration (FDA) has awarded “Qualified Infectious Disease Product” (QIDP) Designation to EVO100 (the investigational name for Phexxi®.

February 9, 2022

·

4 min read